BILL ANALYSIS Ó
------------------------------------------------------------
|SENATE RULES COMMITTEE | ACR 26|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
------------------------------------------------------------
THIRD READING
Bill No: ACR 26
Author: Galgiani (D), et al.
Amended: 6/1/11 in Senate
Vote: 21
ASSEMBLY FLOOR : Read and adopted, 4/7/11
SUBJECT : Chronic obstructive pulmonary disease awareness
SOURCE : American Lung Association of California
Boehringer Ingelheim Pharmaceuticals, Inc.
DIGEST : This resolution encourages the State Department
of Health Care Services to, whenever possible, partner with
private entities to improve education regarding chronic
obstructive pulmonary disease (COPD); declares November
2011, as Chronic Obstructive Pulmonary Disease Awareness
Month in California; and encourages public officials and
the citizens of California to increase awareness about the
symptoms of, and the methods of, preventing COPD.
ANALYSIS : This resolution makes the following
legislative findings:
1.COPD, also known as chronic bronchitis and emphysema, is
the fourth leading cause of death in the United States;
and, its prevalence and death rate is rising.
2.COPD is a chronic and progressive disease that impacts an
estimated 24 million Americans each year; and, many
CONTINUED
ACR 26
Page
2
patients suffering with COPD are not diagnosed until they
have reached an advanced state which often includes a
disabling degree of lung dysfunction.
3.A diagnostic test for COPD, known as spirometry, is
available for office use, allowing early diagnosis of
COPD; and, early diagnosis and management of COPD can
lead to an improved quality of life and self-sufficiency
for patients who receive publicly funded benefits,
including Medi-Cal.
4.The "Healthy People 2010" project of the Centers for
Disease Control and Prevention and the National
Institutes of Health concludes that primary care
physicians are in a key position to provide optimal care
to patients with COPD; and these physicians need to be
trained in the latest methods for diagnosing and treating
the disease.
FISCAL EFFECT : Fiscal Com.: No
SUPPORT : (Verified 9/6/11)
American Lung Association of California (co-source)
Boehringer Ingelheim Pharmaceuticals, Inc. (co-source)
CTW:do 9/6/11 Senate Floor Analyses
SUPPORT/OPPOSITION: SEE ABOVE
**** END ****